Combined administration of a hypoxia-activated prodrug, such as TH 302, and a MEK kinase inhibitor, such as pimasertib, are efficacious in the treatment of cancer including pancreatic cancer.
联合使用缺氧活化前药物(如TH 302)和MEK激酶
抑制剂(如Pimasertib)在治疗癌症,包括胰腺癌方面是有效的。